DiaMonTech AG is a Berlin-based MedTech company focused on revolutionizing diabetes care through a patented, non-invasive blood-glucose monitoring technology. The device enables users to measure glucose levels without finger-pricking, aiming to improve patient comfort and compliance. The company has received multiple accolades, including the Health-i Award and the Berlin Senate’s Deep Tech Award, underscoring its technological credibility. Newly secured funding will be directed toward obtaining regulatory approvals and launching the product in European and U.S. markets. Management views the latest investment as validation of strong support for deep-tech innovation from German and international backers. While no specific revenue or user figures were disclosed, the fresh capital positions DiaMonTech to transition from development to commercial rollout and scale its operations internationally.

Total raised

$17M

Funding rounds

3

Latest round

Equity

Latest activity

Sep 2025